GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » Equity-to-Asset

Thalys Medical Technology Group (SHSE:603716) Equity-to-Asset : 0.34 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Thalys Medical Technology Group's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ¥1,069 Mil. Thalys Medical Technology Group's Total Assets for the quarter that ended in Sep. 2024 was ¥3,134 Mil. Therefore, Thalys Medical Technology Group's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.34.

The historical rank and industry rank for Thalys Medical Technology Group's Equity-to-Asset or its related term are showing as below:

SHSE:603716' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34   Med: 0.47   Max: 0.78
Current: 0.34

During the past 13 years, the highest Equity to Asset Ratio of Thalys Medical Technology Group was 0.78. The lowest was 0.34. And the median was 0.47.

SHSE:603716's Equity-to-Asset is ranked worse than
78.76% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.635 vs SHSE:603716: 0.34

Thalys Medical Technology Group Equity-to-Asset Historical Data

The historical data trend for Thalys Medical Technology Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group Equity-to-Asset Chart

Thalys Medical Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.42 0.36 0.35 0.36

Thalys Medical Technology Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.36 0.36 0.35 0.34

Competitive Comparison of Thalys Medical Technology Group's Equity-to-Asset

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's Equity-to-Asset falls into.


;
;

Thalys Medical Technology Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Thalys Medical Technology Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1210.913/3341.784
=0.36

Thalys Medical Technology Group's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=1068.852/3134.269
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thalys Medical Technology Group  (SHSE:603716) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Thalys Medical Technology Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Thalys Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Executives
Wang Jun Ming senior management
Wang Zheng senior management
Wang Wen Bin senior management
Liu Wen Hao Director
Huang Yong Xi senior management
Lei Xian Kun Director
Fan Li Director
Liu Yuan senior management
Wan Li Bo senior management
Wen Wei Director
Chou Jian senior management
Song Yu Director

Thalys Medical Technology Group Headlines

No Headlines